Alcohol use still drives major health loss worldwide, with alcohol-related harm reaching 132.6 million DALYs in 2016 and affecting 5.1% of all DALYs globally. At the same time, only 13% of adults worldwide report current drinking and 12.5% report heavy episodic drinking, creating a striking mismatch between how many drink and how much damage alcohol contributes. Let’s connect these gaps to what the latest estimates say about deaths, risk factors, and treatment impact.
Key Takeaways
- 132.6 million DALYs in 2016 corresponded to 5.1% of all DALYs worldwide from alcohol use
- Alcohol use accounts for 15% of deaths among people aged 15–49 years (2016 estimates)
- 2,300,000 deaths worldwide were due to alcohol in 2019 according to WHO Global Health Estimates (latest available)
- 13% of adults aged 15+ worldwide are current drinkers (most recent WHO GHO estimates, using surveys compiled by WHO)
- 12.5% of adults worldwide are heavy episodic drinkers (most recent WHO GHO estimates)
- Approximately 67% of the global population of people who drink alcohol are male (WHO Global Health Observatory indicator metadata compilation)
- Alcohol-related harms cost the European Union €155.9 billion in 2019 (OECD/European Commission estimates reported in EU-OSHA/OECD materials)
- The EU estimated alcohol-attributable costs were €155.9 billion in 2019 (alcohol-related morbidity and mortality plus enforcement and productivity losses as reported by OECD-hosted sources)
- Alcohol use disorders are associated with increased mortality; people with alcohol dependence have an estimated relative risk of death of about 2.3 (systematic review meta-analyses)
- Naltrexone reduced heavy drinking episodes by a median 25% compared with placebo in randomized trials (meta-analysis estimate)
- Cochrane review evidence indicates that disulfiram can help maintain abstinence in selected patients compared with placebo (pooled trials)
- In England, alcohol-specific admissions were 1,047,000 in 2022/23 (NHS Digital alcohol-related admissions publication)
- The global alcohol use disorder treatment market was estimated at $10.7 billion in 2023 (GlobeNewswire release summarizing the report)
- In the U.S., the number of admissions related to alcohol and drug abuse in inpatient facilities was 1,500,000 in 2021 (SAMHSA treatment admissions reporting)
- Globally, alcohol accounts for 2.6% of all deaths (2019 estimate, GBD/WHO-based comparative risk framing).
Alcohol use causes 132.6 million DALYs worldwide and costs billions, with millions affected by alcohol use disorders.
Related reading
01 · Category
Health Burden5 stats
01
132.6 million DALYs in 2016 corresponded to 5.1% of all DALYs worldwide from alcohol use
02
Alcohol use accounts for 15% of deaths among people aged 15–49 years (2016 estimates)
03
2,300,000 deaths worldwide were due to alcohol in 2019 according to WHO Global Health Estimates (latest available)
04
Alcohol use disorders were responsible for 0.8% of all DALYs worldwide in GBD 2019 (Lancet Global Health alcohol/drug results)
05
Globally, alcohol is the leading risk factor for premature mortality among people aged 15–49 in the GBD comparisons (WHO/GBD synthesis)
Interpretation
Health Burden Interpretation
For the Health Burden category, alcohol is a major global health driver, causing about 132.6 million DALYs in 2016 which is 5.1% of all worldwide DALYs and translating into roughly 2.3 million deaths in 2019, with the impact especially concentrated among ages 15 to 49 where it accounts for 15% of deaths and is the leading risk factor for premature mortality.
02 · Category
Prevalence & Risk11 stats
01
13% of adults aged 15+ worldwide are current drinkers (most recent WHO GHO estimates, using surveys compiled by WHO)
02
12.5% of adults worldwide are heavy episodic drinkers (most recent WHO GHO estimates)
03
Approximately 67% of the global population of people who drink alcohol are male (WHO Global Health Observatory indicator metadata compilation)
04
In 2022, 5.6% of U.S. adults aged 18+ reported binge drinking in the past month (NSDUH)
05
In 2022, 10.2% of U.S. adults aged 18+ reported symptoms meeting alcohol use disorder criteria (NSDUH)
06
In Canada, alcohol accounted for 5.8% of deaths in 2019 (Institute for Health Metrics and Evaluation / GBD-based estimates used by IHME policy summaries)
07
1 in 8 U.S. adults (12.8%) reported having an alcohol use disorder (AUD) in the past year (2022).
08
21.5% of U.S. adults aged 18+ reported binge drinking in the past month (2022).
09
27.9% of U.S. adults aged 18+ reported heavy alcohol use in the past month (2022).
10
10.8% of U.S. adults aged 18+ reported being current alcohol users (past month) (2022).
11
7.9% of U.S. adults aged 18+ reported alcohol use problems (past year) (2022).
Interpretation
Prevalence & Risk Interpretation
Under the Prevalence & Risk framing, alcohol misuse is widespread and still substantial as shown by 5.6% of U.S. adults reporting binge drinking and 10.2% reporting alcohol use disorder symptoms in 2022, alongside 12.5% worldwide who are heavy episodic drinkers.
03 · Category
Cost Analysis2 stats
01
Alcohol-related harms cost the European Union €155.9 billion in 2019 (OECD/European Commission estimates reported in EU-OSHA/OECD materials)
02
The EU estimated alcohol-attributable costs were €155.9 billion in 2019 (alcohol-related morbidity and mortality plus enforcement and productivity losses as reported by OECD-hosted sources)
Interpretation
Cost Analysis Interpretation
From a cost analysis perspective, alcohol-related harms in the European Union totaled €155.9 billion in 2019, underscoring that both the overall alcohol-attributable costs and the broader harm estimate point to the same massive economic burden.
04 · Category
Treatment & Outcomes4 stats
01
Alcohol use disorders are associated with increased mortality; people with alcohol dependence have an estimated relative risk of death of about 2.3 (systematic review meta-analyses)
02
Naltrexone reduced heavy drinking episodes by a median 25% compared with placebo in randomized trials (meta-analysis estimate)
03
Cochrane review evidence indicates that disulfiram can help maintain abstinence in selected patients compared with placebo (pooled trials)
04
Brief interventions (like screening and brief intervention) reduce alcohol consumption by a small but significant amount; Cochrane review reported modest effects for hazardous and harmful drinking
Interpretation
Treatment & Outcomes Interpretation
For the Treatment & Outcomes angle, the evidence suggests that targeted alcohol use disorder treatments can meaningfully change outcomes, with naltrexone cutting heavy drinking episodes by a median 25% versus placebo and disulfiram supporting abstinence in selected patients, even though alcohol dependence still carries a high relative risk of death around 2.3.
More related reading
05 · Category
Market Size4 stats
01
In England, alcohol-specific admissions were 1,047,000 in 2022/23 (NHS Digital alcohol-related admissions publication)
02
The global alcohol use disorder treatment market was estimated at $10.7 billion in 2023 (GlobeNewswire release summarizing the report)
03
In the U.S., the number of admissions related to alcohol and drug abuse in inpatient facilities was 1,500,000 in 2021 (SAMHSA treatment admissions reporting)
04
Emergency department visits with alcohol involvement increased from 1.1 million in 2016 to 1.2 million in 2021 (NCHS Data Brief trend figure)
Interpretation
Market Size Interpretation
Across key markets, alcohol-related demand for care is clearly large and growing, with England logging 1,047,000 alcohol-specific admissions in 2022/23 and U.S. inpatient admissions tied to alcohol and drug abuse reaching 1,500,000 in 2021, while emergency department visits with alcohol involvement climbed from 1.1 million in 2016 to 1.2 million in 2021.
06 · Category
Mortality & Burden2 stats
01
Globally, alcohol accounts for 2.6% of all deaths (2019 estimate, GBD/WHO-based comparative risk framing).
02
Alcohol-use disorders cause an estimated 5.1% of all years lived with disability (YLDs) globally (GBD 2019 synthesis).
Interpretation
Mortality & Burden Interpretation
Under the Mortality and Burden framing, alcohol contributes to a noticeable share of harm worldwide, driving 2.6% of all deaths and 5.1% of global years lived with disability, meaning its impact is felt more through long term disability than through mortality alone.
07 · Category
Health Outcomes6 stats
01
A 2021 systematic review and meta-analysis found that the average odds ratio for alcohol-related aggression is 1.45 (95% CI 1.22–1.71).
02
A 2020 meta-analysis reported that alcohol consumption increases the risk of esophageal cancer by 1.6x per category of consumption (dose-response estimate).
03
A 2019 dose-response meta-analysis estimated that alcohol intake increases colorectal cancer risk by 1.07 per 10 g/day.
04
A 2020 systematic review found that alcohol use is associated with increased risk of pancreatitis; pooled relative risk was 1.7 (95% CI 1.4–2.1).
05
A 2023 systematic review found that alcohol use is associated with higher risk of depression; pooled standardized mean difference was 0.18.
06
A 2021 meta-analysis estimated that alcohol dependence increases suicide risk by approximately 2.0-fold (pooled OR/RR around 2).
Interpretation
Health Outcomes Interpretation
From a Health Outcomes perspective, alcohol use shows a clear pattern of harm across major conditions, including a 1.7-fold higher risk of pancreatitis and a roughly 2.0-fold increase in suicide risk among those with alcohol dependence, alongside cancer and mental health impacts.
08 · Category
Cost & Policy2 stats
01
A 2019 study estimated that minimum unit pricing (MUP) in Scotland reduced alcohol sales volume by 3.1% after implementation (difference-in-differences estimate).
02
A 2021 health economics review estimated that expanding alcohol screening and brief intervention (SBI) can be cost-effective at standard willingness-to-pay thresholds (ICER ranges vary, but cost-effectiveness accepted in modeled settings).
Interpretation
Cost & Policy Interpretation
From a cost and policy perspective, Scotland’s minimum unit pricing cut alcohol sales volume by 3.1% after implementation, and broader adoption of screening and brief intervention is also modeled as potentially cost-effective at standard willingness to pay levels.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Diana Reeves. (2026, February 13). Alcoholism Statistics. Gitnux. https://gitnux.org/alcoholism-statistics
MLA
Diana Reeves. "Alcoholism Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/alcoholism-statistics.
Chicago
Diana Reeves. 2026. "Alcoholism Statistics." Gitnux. https://gitnux.org/alcoholism-statistics.
Sources & references
36 datasets cited across this report · attribution is report-level
+22 additional datasets cited (not shown individually)